Status:

COMPLETED

Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborating Sponsors:

GE Healthcare

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

Objectives: Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.

Detailed Description

Routine PET/CT scans are taken while patients are breathing normally. The motions made by breathing can reduce the image quality of the scan. Minimizing the effects of this motion by taking the images...

Eligibility Criteria

Inclusion

  • Patients with lung or liver lesions measuring 0.5-2cm in diameter will be considered.
  • Patients that are scheduled to be imaged in the PET/CT suite at the Mays Building will only be considered.

Exclusion

  • Pediatric patients (younger than 18 years) will be excluded.
  • Patients that cannot tolerate being scanned for an additional 10 minutes with arms above their head will be excluded.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00843219

Start Date

March 1 2009

End Date

December 1 2011

Last Update

February 17 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT MD Anderson Cancer Center

Houston, Texas, United States, 77030